Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-063821
Filing Date
2025-06-30
Accepted
2025-06-30 07:49:57
Documents
2
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2519257d1_6k.htm 6-K 11239
2 EXHIBIT 99.1 tm2519257d1_ex99-1.htm EX-99.1 15562
  Complete submission text file 0001104659-25-063821.txt   27992
Mailing Address INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052
Business Address INDUSTRIEPARK ZWIJNAARDE 7 BUILDING C B-9052 ZWIJNAARDE C9 B-9052 32 (9) 310 34 00
ARGENX SE (Filer) CIK: 0001697862 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38097 | Film No.: 251088767
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)